SOPH
SOPH: Muken Ross discloses a sale
Muken Ross reported Sale in SOPHiA GENETICS SA: 9838 units of Ordinary Shares, dated 2026-10-05. The full Form 4 contains 1 transaction entry.
SOPH
Muken Ross reported Sale in SOPHiA GENETICS SA: 9838 units of Ordinary Shares, dated 2026-10-05. The full Form 4 contains 1 transaction entry.
SOPH
Xu Zhenyu reported Sale in SOPHiA GENETICS SA: 7394 units of Ordinary Shares, dated 2026-10-05. The full Form 4 contains 1 transaction entry.
SOPH
Camblong Jurgi reported Sale in SOPHiA GENETICS SA: 40172 units of Ordinary Shares, dated 2026-10-05. The full Form 4 contains 1 transaction entry.
SOPH
Menu Philippe reported Sale in SOPHiA GENETICS SA: 7394 units of Ordinary Shares, dated 2026-10-05. The full Form 4 contains 1 transaction entry.
SOPH
CARDOZA GEORGE reported Sale in SOPHiA GENETICS SA: 1592 units of Ordinary Shares, dated 2026-10-05. The full Form 4 contains 1 transaction entry.
SOPH
Puylaert Kevin reported Sale in SOPHiA GENETICS SA: 185 units of Ordinary Shares, dated 2026-10-05. The full Form 4 contains 2 transaction entries.
SOPH
Verma Abhimanyu reported Sale in SOPHiA GENETICS SA: 5284 units of Ordinary Shares, dated 2026-10-05. The full Form 4 contains 1 transaction entry.
SOPH
Valente Manuela reported Sale in SOPHiA GENETICS SA: 4240 units of Ordinary Shares, dated 2026-10-05. The full Form 4 contains 1 transaction entry.
SOPH
Van Well Daan reported Sale in SOPHiA GENETICS SA: 6168 units of Ordinary Shares, dated 2026-10-05. The full Form 4 contains 1 transaction entry.
MRNA
Mock James M reported Exercise or conversion in Moderna, Inc.: 1454 units of Common Stock, dated 2026-10-05. The full Form 4 contains 3 transaction entries.
AAOI
Yeh Shu-Hua (Joshua) reported Sale in APPLIED OPTOELECTRONICS, INC.: 6000 units of Common Stock, $.001 par value, dated 2026-10-05. The full Form 4 contains 1 transaction entry.
HUMA
Kuznik Paul Brian reported Grant or award in Humacyte, Inc.: 125000 units of Stock Options (right to buy) (derivative), dated 2026-10-06. The full Form 4 contains 1 transaction entry.
CSIQ
Ruda Harry E reported Exercise or conversion in Canadian Solar Inc.: 1203 units of Common Stock, dated 2026-10-06. The full Form 4 contains 3 transaction entries.
PEB
Bayless William C Jr reported Grant or award in Pebblebrook Hotel Trust: 2658 units of Common Shares, dated 2026-10-01. The full Form 4 contains 1 transaction entry.
HUMA
COWARD D SCOTT reported Grant or award in Humacyte, Inc.: 125000 units of Stock Options (right to buy) (derivative), dated 2026-10-06. The full Form 4 contains 1 transaction entry.
PRGS
WANG YUFAN STEPHANIE reported Sale in PROGRESS SOFTWARE CORP /MA: 1245 units of Common Stock, dated 2026-10-05. The full Form 4 contains 1 transaction entry.
INTA
HALL JOHN T reported Exercise or conversion in Intapp, Inc.: 3000 units of Common Stock, dated 2026-10-05. The full Form 4 contains 3 transaction entries.
CLNE
Armstrong Jason J. reported 35,000 shares of Common Stock in Clean Energy Fuels Corp. as grants or awards dated 2026-10-06. The Form 4 was disclosed on Oct 7, 2026. These were stock awards, not open-market purchases.
ATEN
Henry Mary C reported 7,981 shares of Common Stock in A10 Networks, Inc. as grants or awards dated 2026-10-05. The Form 4 was disclosed on Oct 7, 2026. These were stock awards, not open-market purchases.
ATEN
Caron Michelle Elizabeth reported Tax/exercise withholding in A10 Networks, Inc.: 1743 units of Common Stock, dated 2026-10-05. The full Form 4 contains 1 transaction entry.
PCVX
Cowan Elvia reported Exercise or conversion in Vaxcyte, Inc.: 19000 units of Common Stock, dated 2026-10-05. The full Form 4 contains 3 transaction entries.
FOA
Prahm Jeremy reported Sale in Finance of America Companies Inc.: 6000 units of Class A Common Stock, dated 2026-10-05. The full Form 4 contains 1 transaction entry.
TIPT
Goldwasser Lesley reported 1,084 shares of Common Stock in TIPTREE INC. as grants or awards dated 2026-10-06. The Form 4 was disclosed on Oct 7, 2026. These were stock awards, not open-market purchases.
ULS
Kini Vikram reported Grant or award in UL Solutions Inc.: 278 units of Deferred Stock Units (derivative), dated 2026-10-05. The full Form 4 contains 1 transaction entry.